文献速递脑血管病

聚焦脑出血所致卒中的随机试验特征:系统综述

Characteristics of Randomized Trials Focusing on Stroke due to Intracerebral Hemorrhage: Systematic Review.
PubMed 文献 · Stroke · 2018-02-12

该系统综述检索 Cochrane 卒中组试验注册库,纳入 136 项脑出血成人随机对照试验,分析其发表年份、语言、研究特征与效应量。结果显示 76% 为单中心、57% 为 II 期、中位样本量 77 例,仅 28% 偏倚风险较低;低偏倚风险试验更可能多中心招募并以英文发表,且对死亡/残疾的合并治疗效应更小。

要点

  • 136 项脑出血随机对照试验中 76% 为单中心、57% 为 II 期,中位样本量仅 77 例。
  • 仅 38 项(28%)偏倚风险较低,低偏倚风险试验更可能多中心招募并以英文发表。
  • 低偏倚风险试验对死亡/残疾的合并治疗效应更小(P=0.02)。

核心结论

  • 脑出血随机对照试验常存在高偏倚风险,这些试验以样本量小和效应量大为特征。

研究设计与样本

  • 系统综述,检索 Cochrane 卒中组试验注册库(2015 年 12 月),纳入报告脑出血成人临床结局的已完成并发表的随机对照试验,共 136 项。
  • 将描述随机化、使用盲法或明确主要结局中至少完成 2 项者视为偏倚风险较低,并已在 PROSPERO 注册(CRD42016051103)。

主要发现

  • 136 项试验中 57% 为 II 期、76% 为单中心、98% 研究急性期治疗、49% 涉及药物干预、24% 为安慰剂对照,30% 以死亡或残疾为主要结局,中位样本量 77 例(四分位距 47-160)。
  • 46% 解释了随机化、24% 对治疗分配设盲、24% 明确了主要结局,故 38 项(28%)偏倚风险较低。
  • 偏倚风险较低的试验更可能采用多中心招募(校正比值比 6.95;95% 置信区间 2.2-21.5)并以英文发表(校正比值比 12.9;95% 置信区间 2.7-62.5)。
  • 样本量较大的试验独立地更可能为 III/IV 期(P<0.01)并采用多中心招募(P<0.01)。
  • 偏倚风险较低的试验对死亡/残疾的合并治疗效应更小(P=0.02)。

关键数值与推荐

  • 偏倚风险较低定义为描述随机化、使用盲法或明确主要结局中至少完成 2 项。
  • 多中心招募与低偏倚风险的校正比值比 6.95(95% 置信区间 2.2-21.5)。
  • 英文发表与低偏倚风险的校正比值比 12.9(95% 置信区间 2.7-62.5)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The absence of treatments for intracerebral hemorrhage with significant consistent benefit in randomized controlled trials (RCTs) could be because of lack of treatment efficacy or the design of RCTs. METHODS: We searched the Cochrane Stroke Group Trials Register in December 2015 for completed and published RCTs reporting clinical outcome in adults with intracerebral hemorrhage. We collected data on publication year and language, study characteristics, and effect size. We regarded RCTs to be at lower risk of bias if they performed ≥2 of describing randomization, using blinding, or specifying the primary outcome. We registered this systematic review (PROSPERO, international prospective register of systematic reviews CRD42016051103). RESULTS: We found 136 eligible RCTs: 57% were phase II, 76% were single center, 98% studied acute treatments, 49% involved drug interventions, 24% were placebo-controlled, the primary outcome was death or disability in 30%, and median sample size was 77 (interquartile range, 47-160). Forty-six percent explained randomization, 24% blinded treatment allocation, and 24% specified the primary outcome such that 38 (28%) were at lower risk of bias. RCTs at lower risk of bias were more likely to use multicenter recruitment (adjusted odds ratio, 6.95; 95% confidence interval, 2.2-21.5) and be published in English (adjusted odds ratio, 12.9, 95% confidence interval, 2.7-62.5). RCTs with larger sample sizes were independently more likely to be phase III/IV (P<0.01) and use multicenter recruitment (P<0.01). RCTs at lower risk of bias had smaller pooled treatment effects on death/disability (P=0.02). CONCLUSIONS: Intracerebral hemorrhage RCTs have often been at high risk of bias, and these RCTs have been characterized by small sample sizes and larger effect sizes.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Tamborska A, Poon MTC, Al-Shahi Salman R, et al. Characteristics of Randomized Trials Focusing on Stroke due to Intracerebral Hemorrhage: Systematic Review. Stroke. 2018. PMID: 29440585. doi:10.1161/STROKEAHA.117.019227

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。